Original language | English |
---|---|
Article number | 1251P |
Pages (from-to) | viii446 |
Number of pages | 1 |
Journal | Annals of Oncology |
Volume | 29 |
Issue number | Supplement 8 |
DOIs | |
Publication status | Published - 1 Oct 2018 |
Event | 43rd European Society for Medical Oncology Congress (ESMO 2018) - Munich, Germany Duration: 19 Oct 2018 → 23 Oct 2018 |
Adverse events (AEs) over time in patients (pts) treated with adjuvant dabrafenib plus trametinib (D + T) or placebo (Pbo) in the COMBI-AD trial
V. G. Atkinson, A. Hauschild, M. Santinami, M. Mandala, V. Chiarion Sileni, J. Larkin, M. S. Nyakas, C. Dutriaux, A. Haydon, L. Mortier, C. Robert, J. Schachter, D. Schadendorf, X. Feng, E. de Jong, B. Mookerjee, R. Kefford, R. Dummer, J. M. Kirkwood, G. V. Long
Research output: Contribution to journal › Meeting abstract › peer-review